Paolo Antonucci

ORCID: 0000-0001-6719-2447
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Biochemical Analysis and Sensing Techniques
  • Long-Term Effects of COVID-19
  • COVID-19 and Mental Health
  • Advanced Chemical Sensor Technologies
  • Oral and Maxillofacial Pathology
  • COVID-19 Clinical Research Studies
  • Olfactory and Sensory Function Studies
  • Ear and Head Tumors
  • Head and Neck Surgical Oncology
  • Salivary Gland Tumors Diagnosis and Treatment
  • Head and Neck Cancer Studies

University of Trieste
2020-2021

Ospedale di Cattinara
2020

University of Rome Tor Vergata
2014

Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection can cause a wide array of symptoms ranging from mild to severe or fatal forms coronavirus disease 2019 (COVID-19).1 Furthermore, it has been observed that in proportion patients variable range may persist for long time.2 An increasing number studies have focused on COVID, but they mainly concentrated previously hospitalized COVID-19 reporting up 6-months after illness.3, 4 The main aim this study was evaluate the...

10.1002/alr.22832 article EN cc-by-nc-nd International Forum of Allergy & Rhinology 2021-06-09

The aim of the present study was to estimate 1 year prevalence and recovery rate self-reported chemosensory dysfunction in a series subjects with previous mild-to-moderate symptomatic COVID-19.Prospective based on SNOT-22, item "sense smell or taste" additional outcomes.268/315 patients (85.1%) completing survey at baseline also completed follow-up interview. 12 months COVID-19 associated 21.3% (95% CI 16.5-26.7%). Of 187 who complained baseline, 130 (69.5%; 95% 62.4-76.0%) reported complete...

10.1007/s00405-021-06839-w article EN other-oa European Archives of Oto-Rhino-Laryngology 2021-05-07

Abstract Background In a proportion of patients recovered from the acute COVID-19 phase, variable range symptoms has been observed to persist for at least 6-months. Objectives The main aim this study was evaluate prevalence COVID-related 12-months after onset mild-to-moderate disease. Methods Prospective based on structured questionnaires and additional outcomes. Results 304/354 completing survey baseline also completed follow-up interview (85.9%; median [range] age, 47 [18-76] years; 185...

10.1101/2021.04.12.21255343 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2021-04-13

Abstract Purpose The aim of the present study was to estimate one-year prevalence and recovery rate self-reported chemosensory dysfunction in a series subjects with previous mild-to-moderate symptomatic COVID-19. Methods Prospective based on SNOT-22 (item sense smell or taste) additional outcomes. Results 268/315 patients (85.1%) completing survey at baseline also completed follow-up interview. 12-months COVID-19 associated 21.3% (95% CI: 16.5-26.7%). Of 187 who complained baseline, 130...

10.1101/2021.03.18.21253862 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2021-03-24

Warthin's tumor is the second most common benign neoplasm of parotid.Most cases are represented by a single localization, while only small percentage patients presents bilateral lesions or unilateral multifocal pattern.Warthin's has an excellent prognosis due to low rate recurrence after surgical treatment.Malignant transformation occurs in less than 1% cases.The aim this article present two unusual and updated review latest scientific literature.

10.11138/orl/2014.7.1.025 article EN Oral & Implantology 2014-01-01
Coming Soon ...